Importantly, human NK cell marker CD56 was detected in tumor tissues of mice treated with NK cells via systemic administration (Figure 8B), suggesting that allogeneic NK cells can localize to and infiltrate the tumor tissues. This evidence concerns the gene NCAM1 and neoplasm.